7 Einträge gefunden

1. HLA-mismatched unrelated donors as an alternative graft source for allogeneic stem cell transplantation after antithymocyte globulin-containing conditioning regimen.

   1. Kröger, Nicolaus
   2. Zabelina, Tatjana
   3. Binder, Thomas
   4. Ayuketang Ayuk, Francis
   5. Bacher, Ulrike
   6. Amtsfeld, Gitta
   7. Lellek, Heinrich

   2009 - Forschungsinformationssystem des UKE
2. Outcome of allo-SCT for chronic myelomonocytic leukemia.

   1. Ocheni, Sunday
   2. Kröger, Nicolaus
   3. Zabelina, Tatjana
   4. Zander, Axel R.
   5. Bacher, Ulrike

   2009 - Forschungsinformationssystem des UKE
3. Post-transplant immunotherapy with donor-lymphocyte infusion and novel agents to upgrade partial into complete and molecular remission in allografted patients with multiple myeloma.

   1. Kröger, Nicolaus
   2. Badbaran, Anita
   3. Lioznov, Michael
   4. Schwartz, Sabine
   5. Zeschke, Silke
   6. Hildebrandt, York
   7. Ayuketang Ayuk, Francis

   2009 - Forschungsinformationssystem des UKE
4. Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.

   1. Klyuchnikov, Evgeny
   2. Schafhausen, Philippe
   3. Kröger, Nicolaus
   4. Brümmendorf, Tim
   5. Osanmaz, Okay
   6. Asenova, Svetlana
   7. Zabelina, Tatjana

   2009 - Forschungsinformationssystem des UKE
5. Second allogeneic stem cell transplantation in myeloid malignancies.

   1. Hartwig, Maite
   2. Ocheni, Sunday
   3. Asenova, Svetlana
   4. Wiedemann, Bettina
   5. Zabelina, Tatjana
   6. Ayuketang Ayuk, Francis
   7. Kabisch, Hartmut

   2009 - Forschungsinformationssystem des UKE
6. Pegfilgrastim compared to lenograstim after allogeneic peripheral blood stem-cell transplantation from unrelated donors.

   1. Ocheni, Sunday
   2. Zabelina, Tatjana
   3. Bacher, Ulrike
   4. Ayuketang Ayuk, Francis
   5. Zander, Axel R.
   6. Kröger, Nicolaus

   2009 - Forschungsinformationssystem des UKE
7. Quantitative monitoring of NPM1 mutations provides a valid minimal residual disease parameter following allogeneic stem cell transplantation.

   1. Bacher, Ulrike
   2. Badbaran, Anita
   3. Fehse, Boris
   4. Zabelina, Tatjana
   5. Zander, Axel R.
   6. Kröger, Nicolaus

   2009 - Forschungsinformationssystem des UKE